Spyglass Pharma’s IOL Delivers Compelling 18-Month Visual Acuity Results
SpyGlass Pharma announced positive 18-month data from its first-in-human study of a novel drug delivery platform for glaucoma and...
Search results for:
liver
Heparegenix Secures €21.5M for Liver Regeneration
HepaRegeniX, a clinical-stage company developing therapies for liver diseases, completed a €21.5 million financing round with Wellington Partners. The...
Chemomab’s PSC Trial Shows Positive Liver Biomarker Results
Chemomab Therapeutics announced positive 48-week data from the open-label extension (OLE) of its Phase 2 SPRING trial for nebokitug...
Protara Therapeutics: Choline Deficiency and Liver Injury in Parenteral Support Patients: Encore Presentation of THRIVE-1 Results
Protara Therapeutics announced results from THRIVE-1, a study on choline deficiency and liver injury in patients dependent on parenteral...
ACTG Reveals Promising SLIM Liver Findings at CROI
The AIDS Clinical Trials Group (ACTG) presented findings from their SLIM LIVER study at the 2025 Conference on Retroviruses...
Calidi Delivers Transient Gene Therapy to Tumors
Calidi Biotherapeutics announced preclinical success with its systemic RTNova platform, demonstrating effective delivery of gene therapy payloads to targeted...
Vaxxas HD-MAP Vaccine Delivery Clinical Trial Sets Record
Vaxxas, a clinical-stage biotech company, has completed enrollment for its Phase I clinical trial of an avian influenza A...
Daring Denali Therapeutics MPS II Study Delivers!
Denali Therapeutics announced primary analysis results from a Phase 1/2 study of tividenofusp alfa (DNL310) in 47 participants with...
Micron Biomedical Secures $33M for Needle-Free Delivery
Micron Biomedical secured $16 million in a Series A3 funding round, bringing the total Series A investment to over...
Transforming Biologic Delivery: An Interview with Surf Bio
In this interview, we speak with Bryan Mazlish, CEO of Surf Bio, about their innovative SnapShotÔ technology. Bryan discusses...